Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35482
Title: A case of pleural Mycobacterium tuberculosis infection with reversion of Quantiferon Gold Plus results from positive to negative.
Austin Authors: Goire, N;Suchard, M S;Barling, A;Fernando, R;Dreyer, L;Mahony, A A
Affiliation: Microbiology Department, Australian Clinical Laboratories, Clayton, Victoria, Australia.;University of Wollongong Faculty of Health and Behavioural Sciences: University of Wollongong, Wollongong, New South Wales, Australia.
Microbiology Department, Australian Clinical Laboratories, Clayton, Victoria, Australia.;Chemical Pathology Department, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
Thoracic Surgery Department, Bendigo Hospital, Bendigo Health, Bendigo, Victoria, Australia.
Histopathology Department, Australian Clinical Laboratories, Bendigo, Victoria, Australia.
Microbiology Department, Australian Clinical Laboratories, Clayton, Victoria, Australia.
Infectious Diseases Unit, Bendigo Health, Bendigo, Victoria, Australia.
Infectious Diseases
Issue Date: 2024
Date: 2024
Publication information: Access Microbiology 2024; 6(9)
Abstract: Introduction. Mycobacterium tuberculosis (MTB) infections continue to have a high mortality and morbidity burden globally. Interferon-gamma release assays such as Quantiferon Gold Plus (QFG-Plus) aid in diagnosis of latent TB but diagnosis of pleural TB remains challenging. We present a case of active pleural MTB infection with reversion from positive to negative of IGRA result as well as negative Xpert MTB/RIF Ultra PCR result from tissues obtained from pleural biopsy. Case summary. A 52-year-old otherwise healthy male presented in August 2022 with a 2 week history of pleuritic chest pain associated with modest elevation in inflammatory markers. The patient had had a positive QFG-Plus result in 2018, however QFG-Plus during this admission was negative. Computed-tomography pulmonary angiogram and needle thoracocentesis showed an exudative left pleural effusion with predominant lymphocytes. The patient's symptoms failed to resolve with empiric antimicrobial therapy for community-acquired pneumonia. Broncho-alveolar lavage as well as biopsies of pleural tissues via video-assisted thoracoscopic surgery from the left lower lobe yielded negative results on routine microbiological culture as well as Xpert Ultra PCR. Growth of acid-fast bacilli was noted from mycobacterial cultures of pleural tissues which was identified as MTB. Conclusion. Despite significant technological advances, microbiological diagnosis of MTB infections remains challenging. We document QFG-Plus reversion during development from latent to active pleural TB. Decline in the ability of CD4+ and CD8+ T cells to produce interferon gamma in response to TB antigens (ESAT-6 and CFP-10) was likely associated with loss of host control of latent MTB. This case serves as a reminder that despite exhaustive testing with state-of-art diagnostic platforms, MTB infections can still elude discovery.
URI: https://ahro.austin.org.au/austinjspui/handle/1/35482
DOI: 10.1099/acmi.0.000737.v3
ORCID: 0009-0002-0693-7788
Journal: Access Microbiology
PubMed URL: 39239566
ISSN: 2516-8290
Type: Journal Article
Subjects: IGRA
Mycobacterium tuberculosis
PCR
pleural TB
quantiferon gold
reversion
Appears in Collections:Journal articles

Show full item record

Page view(s)

20
checked on Oct 15, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.